Roivant Sciences Ltd. (ROIV) is highlighted as a promising momentum stock with a Zacks Momentum Style Score of B and a Zacks Rank of #2 (Buy). The company's stock has shown strong performance, with a 6.82% increase over the past week and a 28.35% increase over the past month, outperforming its industry. ROIV has also seen positive earnings estimate revisions, with its full-year consensus estimate improving from -$1.11 to -$1.09 in the past 60 days.
🎉 Thank you for holding LSTR tokens!
Your post has been automatically voted with 6.39% weight.